Wu, C.-E.; Huang, C.-Y.; Chen, C.-P.; Pan, Y.-R.; Chang, J.W.-C.; Chen, J.-S.; Yeh, C.-N.; Lunec, J.
WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13, 3876.
https://doi.org/10.3390/cancers13153876
AMA Style
Wu C-E, Huang C-Y, Chen C-P, Pan Y-R, Chang JW-C, Chen J-S, Yeh C-N, Lunec J.
WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers. 2021; 13(15):3876.
https://doi.org/10.3390/cancers13153876
Chicago/Turabian Style
Wu, Chiao-En, Chen-Yang Huang, Chiao-Ping Chen, Yi-Ru Pan, John Wen-Cheng Chang, Jen-Shi Chen, Chun-Nan Yeh, and John Lunec.
2021. "WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells" Cancers 13, no. 15: 3876.
https://doi.org/10.3390/cancers13153876
APA Style
Wu, C.-E., Huang, C.-Y., Chen, C.-P., Pan, Y.-R., Chang, J. W.-C., Chen, J.-S., Yeh, C.-N., & Lunec, J.
(2021). WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers, 13(15), 3876.
https://doi.org/10.3390/cancers13153876